Korean stocks with four straight quarterly losses
Operating loss in each of the last four quarters. Add more filters below to narrow the list.
Add filters earnings · returns · ownership · events · caution · market · industry · sort
Shareholder returns
News & events
Caution
Industry
AllPublishing & softwarePharmaceuticalsFinancial servicesFood productsChemicalsGeneral constructionFinancial & insurance support servicesWholesale tradeElectronics & telecom equipmentRetailElectrical equipmentMachinery & equipmentOther transport equipmentAirlinesMedical, precision & optical instruments
463 Korean listed companies match this signal: operating loss in each of the last four quarters. Based on Q2 2026 reports. 62 are on KOSPI and 401 on KOSDAQ. Sorted by most news articles in the past 24 hours, the list starts with Penetrium Bioscience, Daehan Synthetic Fibrer and Lincsolution.
4 quarters of losses 463
| Company | Articles 24h | Latest quarter op. profit | Dividend yield | Signals |
|---|---|---|---|---|
| Penetrium Bioscience KOSDAQ · Medical & pharmaceutical R&D | 10 | −₩1.9bn | – | Major holder adding 4 quarters of losses Share pledge |
| Daehan Synthetic Fibrer KOSPI · Synthetic fibers | 10 | −₩1.1bn | 0.6% | 4 quarters of losses |
| Lincsolution KOSDAQ | 9 | −₩4.6bn | – | Dilution risk 4 quarters of losses |
| ENCell KOSDAQ | 9 | −₩4.7bn | – | 4 quarters of losses |
| Gencurix KOSDAQ | 7 | −₩702m | – | 4 quarters of losses Delisting / halt risk |
| ImmuneOncia Therapeutics KOSDAQ | 6 | −₩4.3bn | – | Clinical trial filing 4 quarters of losses |
| Voronoi KOSDAQ | 6 | −₩29.3bn | – | Clinical trial filing 4 quarters of losses |
| Kmpharmaceutical KOSDAQ · Specialty chemicals | 6 | −₩585m | – | 4 quarters of losses Delisting / halt risk |
| Coreline Soft KOSDAQ · Software publishing | 6 | −₩2.4bn | – | 4 quarters of losses |
| Stcube KOSDAQ | 6 | −₩6.1bn | – | 4 quarters of losses |
| Kakao Games KOSDAQ | 6 | −₩23.0bn | – | 4 quarters of losses |
| Ictk KOSDAQ | 6 | −₩1.9bn | – | 4 quarters of losses |
| E8 KOSDAQ | 5 | −₩2.5bn | – | Control change Dilution risk 4 quarters of losses |
| Curiosis KOSDAQ | 5 | −₩1.9bn | – | 4 quarters of losses |
| Lightron Fiber-optic Devices KOSDAQ | 5 | −₩2.1bn | – | 4 quarters of losses |
| Hanchang KOSPI · Wholesale trade | 5 | −₩1.2bn | – | 4 quarters of losses |
| KS Industry KOSDAQ | 4 | −₩806m | – | Private placement Dilution risk 4 quarters of losses Insider selling Litigation |
| Doosan Fuel Cell KOSPI | 4 | −₩50.9bn | – | Supply contract 4 quarters of losses |
| Zaram Technology KOSDAQ | 4 | −₩314m | – | Supply contract 4 quarters of losses |
| Genome&Company KOSDAQ | 4 | −₩8.0bn | – | 4 quarters of losses |
| Qurient KOSDAQ | 4 | −₩12.8bn | – | 4 quarters of losses |
| Asiana Airlines KOSPI · Airlines | 4 | −₩356bn | – | 4 quarters of losses |
| G2gbio KOSDAQ | 4 | −₩2.7bn | – | 4 quarters of losses |
| QuantaMatrix KOSDAQ | 4 | −₩4.2bn | – | 4 quarters of losses |
| Xcell Therapeutics KOSDAQ | 4 | −₩2.8bn | – | 4 quarters of losses |
| ABL Bio KOSDAQ | 3 | −₩16.8bn -141% | – | Swung to loss 4 quarters of losses |
| Mgen Solutions KOSDAQ | 3 | −₩2.9bn | – | 4 quarters of losses Litigation |
| Korea Advanced Materials KOSDAQ · Telecom & broadcasting equipment | 3 | −₩596m | – | M&A / stake deal 4 quarters of losses |
| Maum.ai KOSDAQ | 3 | −₩3.0bn | – | Supply contract 4 quarters of losses |
| Genomictree KOSDAQ | 3 | −₩2.6bn | – | 4 quarters of losses |
| Cytogen KOSDAQ | 3 | −₩1.2bn | – | 4 quarters of losses |
| The BORN Korea KOSPI | 3 | −₩5.6bn | – | 4 quarters of losses |
| Beno TNR KOSDAQ | 2 | −₩1.2bn | – | Supply contract Control change Split / consolidation Swung to loss 4 quarters of losses Capital reduction |
| Pintel KOSDAQ | 2 | −₩477m | – | Insider buying 4 quarters of losses Insider selling Delisting / halt risk |
| Haisung Aero-Robotics KOSDAQ | 2 | −₩736m | – | Swung to loss 4 quarters of losses Delisting / halt risk |
| HanWool Semiconductor KOSDAQ | 2 | −₩3.4bn | – | Major holder adding 4 quarters of losses Share pledge |
| SillaJen KOSDAQ | 2 | −₩6.2bn | – | Clinical trial filing 4 quarters of losses |
| HLB KOSDAQ | 2 | −₩22.5bn | – | Revenue +30% 4 quarters of losses |
| Rznomics KOSDAQ | 2 | −₩6.9bn -324% | – | Swung to loss 4 quarters of losses |
| SyntekaBio KOSDAQ | 2 | −₩2.2bn | – | Supply contract 4 quarters of losses |
| JLK KOSDAQ | 2 | −₩3.3bn | – | 4 quarters of losses |
| From Bio KOSDAQ | 2 | −₩553m | – | 4 quarters of losses |
| Higen RNM KOSDAQ | 2 | −₩1.5bn | – | 4 quarters of losses |
| Aps KOSDAQ | 2 | −₩3.9bn | – | 4 quarters of losses |
| Agos KOSDAQ | 2 | −₩2.5bn | – | 4 quarters of losses |
| Orum Therapeutics KOSDAQ | 2 | −₩15.4bn | – | 4 quarters of losses |
| OliX Pharmaceuticals KOSDAQ | 2 | −₩14.0bn | – | 4 quarters of losses |
| Enchem KOSDAQ | 1 | −₩11.6bn | – | Revenue +30% New 5% holder Major holder adding 4 quarters of losses Insider selling Share pledge |
| Enex KOSPI | 1 | −₩3.1bn -300% | – | Major holder adding Swung to loss 4 quarters of losses Share pledge |
| Satoshi Holdings KOSDAQ | 1 | −₩1.6bn | – | Insider buying Major holder adding 4 quarters of losses Insider selling |
| HNK Machine Tool KOSDAQ | 1 | −₩868m | – | Insider buying Supply contract 4 quarters of losses |
| Csa Cosmic KOSDAQ | 1 | −₩5.7bn | – | M&A / stake deal Dilution risk 4 quarters of losses |
| Aribiolab KOSDAQ | 1 | −₩2.5bn | – | Control change Dilution risk 4 quarters of losses |
| Dongkuk Industries Company KOSDAQ | 1 | −₩855m -115% | 5.1% | High dividend Swung to loss 4 quarters of losses |
| MedPacto KOSDAQ | 1 | −₩3.6bn | – | Clinical trial filing 4 quarters of losses |
| HB Solution KOSDAQ | 1 | −₩503m -113% | – | Swung to loss 4 quarters of losses |
| Hyper KOSDAQ | 1 | −₩2.5bn | – | Swung to loss 4 quarters of losses |
| Devsisters KOSDAQ | 1 | −₩16.0bn -258% | – | Swung to loss 4 quarters of losses |
| The Codi KOSDAQ | 1 | −₩1.1bn | – | Swung to loss 4 quarters of losses |
| Neuromeka KOSDAQ | 1 | −₩5.3bn | – | Insider buying 4 quarters of losses |
| Iteyes KOSDAQ | 1 | −₩3.0bn | – | Swung to loss 4 quarters of losses |
| Naurobotics KOSDAQ | 1 | −₩4.2bn | – | 4 quarters of losses Insider selling |
| Kumyang KOSPI | 1 | – | – | M&A / stake deal 4 quarters of losses |
| HLB Global KOSPI | 1 | −₩875m | – | Dilution risk 4 quarters of losses |
| SFA Semicon KOSDAQ | 1 | −₩6.2bn | – | Revenue +30% 4 quarters of losses |
| Episode Company KOSDAQ | 1 | −₩3.1bn | – | Swung to loss 4 quarters of losses |
| Curocell KOSDAQ | 1 | −₩9.7bn | – | 4 quarters of losses Insider selling |
| Alux KOSDAQ | 1 | −₩1.3bn | – | Revenue +30% 4 quarters of losses |
| Laseroptek KOSDAQ | 1 | −₩991m | – | 4 quarters of losses Insider selling |
| Daekyo KOSPI | 1 | −₩3.7bn | 3.1% | Swung to loss 4 quarters of losses |
| SK ie technology KOSPI | 1 | −₩63.4bn | – | M&A / stake deal 4 quarters of losses |
| Naturecell KOSDAQ | 1 | −₩702m | – | 4 quarters of losses |
| Secern AI KOSDAQ | 1 | −₩2.8bn | – | 4 quarters of losses |
| Graphy KOSDAQ | 1 | −₩3.7bn | – | 4 quarters of losses |
| Sigetronics KOSDAQ | 1 | −₩2.1bn | – | 4 quarters of losses |
| Ascendio KOSPI | 1 | −₩692m | – | 4 quarters of losses |
| DHX Company KOSDAQ | 1 | −₩1.1bn | – | 4 quarters of losses |
| Fantagio KOSDAQ | 1 | – | – | 4 quarters of losses |
| Bitplanet KOSDAQ | 1 | −₩767m | – | 4 quarters of losses |
| Peptron KOSDAQ | 1 | −₩7.9bn | – | 4 quarters of losses |
| ToolGen KOSDAQ | 1 | −₩6.9bn | – | 4 quarters of losses |
| SuNAM KOSDAQ | 1 | −₩1.6bn | – | 4 quarters of losses |
| Bitmax KOSDAQ | 1 | −₩779m | – | 4 quarters of losses |
| S2W KOSDAQ | 1 | −₩3.2bn | – | 4 quarters of losses |
| Chonbang KOSPI | 1 | −₩141m | – | 4 quarters of losses |
| iNtRON Biotechnology KOSDAQ | 1 | −₩1.6bn | – | 4 quarters of losses |
| BK Holdings KOSDAQ | 1 | −₩727m | – | 4 quarters of losses |
| Korea Cable T.V Chung-buk System KOSDAQ | 1 | −₩738m | – | 4 quarters of losses |
| HanWool Materials Science KOSDAQ | 1 | −₩3.5bn | – | 4 quarters of losses |
| DSM KOSDAQ | 1 | −₩154m | – | 4 quarters of losses |
| Edge Foundry KOSDAQ | 1 | −₩6.1bn | – | 4 quarters of losses |
| RollingStone KOSDAQ | 1 | −₩1.7bn | – | 4 quarters of losses |
| Woori Technology, In KOSDAQ | 1 | −₩1.1bn | – | 4 quarters of losses |
| Good People KOSDAQ | 1 | −₩1.8bn | – | 4 quarters of losses |
| SD Biosensor KOSPI | 1 | −₩7.3bn | – | 4 quarters of losses |
| Blitzway Entertainment KOSDAQ | 1 | −₩1.1bn | – | 4 quarters of losses |
| STX KOSPI | 1 | −₩18.9bn | – | 4 quarters of losses |
| Deepnoid KOSDAQ | 1 | −₩3.3bn | – | 4 quarters of losses |
| Aprogen Biologics KOSPI | 0 | −₩17.5bn | – | Revenue +30% Major holder adding 4 quarters of losses Share pledge |
| Aprogen KOSPI | 0 | −₩22.4bn | – | Revenue +30% Major holder adding 4 quarters of losses Share pledge |
Signals are generated automatically from DART filings (quarterly results, ownership reports, major-event reports and filing titles) and news counts. Prices and trading flows are not included. Not investment advice.
What this list means
Operating losses in each of the last four quarters. Prolonged losses can be grounds for administrative issue designation on KOSDAQ, with exceptions such as technology-track listings.
Lists are generated automatically from filings and are not investment advice.